Published in Mediterr J Hematol Infect Dis on February 17, 2014
Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med (1994) 15.82
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med (1995) 13.59
High serum procalcitonin concentrations in patients with sepsis and infection. Lancet (1993) 6.67
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med (2000) 6.07
Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci U S A (1989) 5.30
Sickle-cell disease. Lancet (2004) 4.76
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med (2000) 3.77
Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the U.K.: implications for developing management guidelines. Respir Med (1997) 3.38
Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med (2006) 2.77
Procalcitonin in bacterial infections--hype, hope, more or less? Swiss Med Wkly (2005) 2.17
Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis (2002) 2.01
Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med (1999) 1.94
Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol (2009) 1.55
The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut (1997) 1.54
Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J (2007) 1.47
Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials (1995) 1.32
Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection (2007) 1.29
High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis (1999) 1.28
Current issues in sickle cell pain and its management. Hematology Am Soc Hematol Educ Program (2007) 1.22
Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab (1998) 1.18
Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med (2000) 1.06
Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res (1992) 0.94
Clinical and molecular characterization of Hb Hofu in eastern India. Int J Lab Hematol (2013) 0.91
Procalcitonin as a potent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency department. Eur J Clin Microbiol Infect Dis (2011) 0.88
Calcitonin peptides--the mediators in sepsis or just another fairy tale? Crit Care Med (2008) 0.83
Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis? Infection (2011) 0.80
Evaluation of fever in the patient with cancer. Eur J Cancer Clin Oncol (1989) 0.80
Bloodstream infections in hospitalized adults with sickle cell disease: a retrospective analysis. Am J Hematol (2006) 0.77
Procalcitonin is more useful than C-reactive protein in differentiation of fever in patients with sickle cell disease. J Pediatr Hematol Oncol (2012) 0.77
Serum procalcitonin concentration as a negative predictor of serious bacterial infection in acute sickle cell pain crisis. Med Sci Monit (2003) 0.77